Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Alan Graham Pockley

Emeritus Professor of Immunobiology

University of Nottingham

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

LinkedIn ORCID Google Scholar Academic Page

Research Interests

Immunology

60%

Cell Biology

40%

Cancer Biology

40%

Tumor Immunology

30%

Immunotherapy

20%

Flow Cytometry

20%

Immune Response

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

A single-dose DNA vaccine platform to safely induce protective immunity against Zika virus

Open Date: 2022-04-01

Close Date: 2023-04-01

Grant: Close

A novel DNA vaccine that delivers long lasting immunity by stimulating high avidity CD8 T cells and strong neutralising antibodies

Open Date: 2020-10-01

Close Date: 2022-03-01

Grant: Close

Development of new immune-based treatments for Glioblastoma Multiforme (GBM)

Open Date: 2019-09-01

Close Date: 2021-12-01

Grant: Close

Developing a diagnostic tool, using SPAG5, for predicting clinical benefit from standard anthracycline combination (AC) chemotherapy in breast cancer

Open Date: 2018-06-01

Close Date: 2021-12-01

Grant: Close

Autologous Stem cell Transplantation In refractory Crohn’s disease - Low Intensity Therapy Evaluation (ASTIC-LITE)

Open Date: 2017-08-01

Close Date: 2021-05-01

Articles17

Cannabidiol Mediates Beneficial Effects on the Microvasculature of Murine Hearts with Regard to Irradiation-Induced Inflammation and Early Signs of Fibrosis

Article Link

Year:

2025

Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancer.

Article Link

Year:

2025

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.

Article Link

Year:

2024

Extracellular Hsp70 and Circulating Endometriotic Cells as Novel Biomarkers for Endometriosis

Article Link

Year:

2024

Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70-Derived Peptide: A Combined Computational and Experimental Study

Article Link

Year:

2024

TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors

Article Link

Year:

2024

Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers

Article Link

Year:

2023

SARS-Cov-2 Spike RBD and Nucleocapsid Encoding DNA Vaccine Elicits T cell and Neutralising Antibody Responses that Cross React with Variants

Article Link

Year:

2023

From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy

Article Link

Year:

2023

Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 Glioma

Article Link

Year:

2023

Effect of adiposity and physical fitness on cardiometabolic risk factors in adolescents: A 2-year longitudinal study.

Article Link

Year:

2022

Elevated Levels of Circulating Hsp70 and an Increased Prevalence of CD94+/CD69+ NK Cells Is Predictive for Advanced Stage Non-Small Cell Lung Cancer

Article Link

Year:

2022

A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice

Article Link

Year:

2022

Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus

Article Link

Year:

2022

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).

Article Link

Year:

2021

Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data

Article Link

Year:

2021

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development

Article Link

Year:

2021

Collaborators31

William Ying Khee Hwang

Professor and Chair

Duke-NUS Medical School

SINGAPORE

Aneurin James Kennerley

Manchester Metropolitan University

UNITED KINGDOM

Morteza Kafshgari

Technical University of Munich

GERMANY

Guido Heine

GERMANY

Felix Scholkmann

University of Bern

SWITZERLAND

Jose Antonio Garrote

Profesor Titular

Universidad de Valladolid

SPAIN

Gabriele Multhoff

GERMANY

Caroline Sunderland

Reader

University of Nottingham

UNITED KINGDOM

Imke Schatka

Charité - Universitätsmedizin Berlin

GERMANY

Laura Cook

CANADA

Chiara Vasco

ITALY

Peter Vaupel

Professor

University Medical Center

GERMANY

Klaas P.J.M. van Gisbergen

NETHERLANDS

Kylie M Quinn

AUSTRALIA

Leo Hansmann

GERMANY

Chiara Romagnani

Professor

GERMANY

Sebastian Kobold

University Hospital

GERMANY

Nicola Gagliani

University Medical Center Hamburg-Eppendorf

GERMANY

barbara wollenberg

Prof Dr.

GERMANY

Martin Davey

MONASH UNIVERSITY

AUSTRALIA

Ryan Williams

Lecturer in Exercise Physiology

University of Nottingham

UNITED KINGDOM

Dirk Baumjohann

Associate Professor

University of Bonn

GERMANY

Gordon Moran

University of Nottingham

UNITED KINGDOM

Georgina Cosma

Professor

Loughborough University

UNITED KINGDOM

Faith Howard

University of Sheffield

UNITED KINGDOM

Willem van de Veen

SWITZERLAND

S. E. B. McArdle

UNITED KINGDOM

Miguel Muñoz-Ruiz

Universidad Complutense de Madrid

SPAIN

ADRIAN HAYDAY

King’s College London

UNITED KINGDOM

Maximilien Evrard

University of Melbourne

AUSTRALIA

Vanadin Seifert-Klauss

Prof. Dr. med.

Klinikum rechts der Isar der Technischen Universität München

GERMANY

How do I reach out?

Meet Kite AI